These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 2845846)

  • 1. Cytotoxic T lymphocytes. Their relevance in herpesvirus infections.
    Martin S; Cantin E; Rouse BT
    Ann N Y Acad Sci; 1988; 532():257-72. PubMed ID: 2845846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The proportion of herpes simplex virus-specific cytotoxic T lymphocytes (Tc) that recognize glycoprotein C varies between individual mice and is dependent on the form of immunization.
    Martin S; Mercadal CM; Weir JP; Rouse BT
    Viral Immunol; 1993; 6(1):21-33. PubMed ID: 8386515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.
    Rosenthal KL; Smiley JR; South S; Johnson DC
    J Virol; 1987 Aug; 61(8):2438-47. PubMed ID: 3037106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
    Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
    J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
    Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
    J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: clearance of local infection.
    Martin S; Rouse BT
    J Immunol; 1987 May; 138(10):3431-7. PubMed ID: 3033075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. IV. Recognition and activation by cloned glycoproteins gB and gD.
    Zarling JM; Moran PA; Burke RL; Pachl C; Berman PW; Lasky LA
    J Immunol; 1986 Jun; 136(12):4669-73. PubMed ID: 2423598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of antiviral immunity induced by a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: cytotoxic T cells.
    Martin S; Moss B; Berman PW; Laskey LA; Rouse BT
    J Virol; 1987 Mar; 61(3):726-34. PubMed ID: 3027400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An adenovirus-herpes simplex virus glycoprotein B recombinant (Ad-HSV.gB) protects mice against a vaccinia HSV.gB and HSV challenge.
    Endresz V; Berencsi K; Gönczöl E
    Acta Microbiol Immunol Hung; 1995; 42(3):247-54. PubMed ID: 8548197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
    Karem KL; Bowen J; Kuklin N; Rouse BT
    J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Murine cytotoxic T lymphocytes specific for herpes simplex virus type 1 recognize the immediate early protein ICP4 but not ICP0.
    Martin S; Zhu XX; Silverstein SJ; Courtney RJ; Yao F; Jenkins FJ; Rouse BT
    J Gen Virol; 1990 Oct; 71 ( Pt 10)():2391-9. PubMed ID: 2172452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of antiviral immunity using vaccinia virus recombinants expressing cloned genes for herpes simplex virus type 1 glycoproteins.
    Martin S; Cantin E; Rouse BT
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1359-70. PubMed ID: 2543783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D.
    Cruz PE; Khalil PL; Dryden TD; Chiou HC; Fink PS; Berberich SJ; Bigley NJ
    Vaccine; 1999 Mar; 17(9-10):1091-9. PubMed ID: 10195619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
    Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
    Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes specific for herpes simplex virus (HSV) studied using adenovirus vectors expressing HSV glycoproteins.
    Witmer LA; Rosenthal KL; Graham FL; Friedman HM; Yee A; Johnson DC
    J Gen Virol; 1990 Feb; 71 ( Pt 2)():387-96. PubMed ID: 2155292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.
    Banks TA; Allen EM; Dasgupta S; Sandri-Goldin R; Rouse BT
    J Virol; 1991 Jun; 65(6):3185-91. PubMed ID: 1709698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination.
    Rooney JF; Wohlenberg C; Cremer KJ; Moss B; Notkins AL
    J Virol; 1988 May; 62(5):1530-4. PubMed ID: 2833606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Native HSV glycoprotein D subunit vaccine: analysis of in vitro T-cell activation and antigen presentation.
    Ishizaka ST; Mishkin EM
    Viral Immunol; 1991; 4(3):187-93. PubMed ID: 1667262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recognition of herpes simplex virus antigens on the surface of mouse cells of the H-2b haplotype by virus-specific cytotoxic T lymphocytes.
    Jennings SR; Rice PL; Pan S; Knowles BB; Tevethia SS
    J Immunol; 1984 Jan; 132(1):475-81. PubMed ID: 6197457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.